You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Upregulation of miR-183 inhibits the invasion and migration of endometrial stromal cells in endometriosis patients by downregulating Ezrin
- 2. Accord Healthcare receives approval for Hetronifly® (Serplulimab), from the Medicines and Healthcare Regulatory Agency (MHRA) for first-line treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
- 3. Your CT scan could reveal a hidden heart risk—and AI just learned how to find it
- 4. Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer—an open-label phase 2 randomized controlled trial
- 5. Machine learning-based preoperative prediction of perioperative venous thromboembolism in Chinese lung cancer patients: a retrospective cohort study
- 6. Vaccine therapies for glioma: clinical frontiers and potential breakthrough
- 7. Rare metastasis of the urinary bladder from esophageal squamous cell carcinoma: a case report
- 8. CHMP6 as a novel prognostic biomarker in bladder cancer: insights from a comprehensive cell death-related gene risk model
- 9. Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants
- 10. Exploration of the role and mechanism of Rhizoma Paridis total saponins in osteosarcoma based on SPI1/LCN2-mediated ferroptosis
Last updated at 13:26 GMT
Hot News Makers
Health/Pharma Companies
-
140794.02
-
49210.99
-
40762.72
-
30861.85
-
25242.47
-
21456.10
-
10763.48
-
10198.59
-
9354.91
-
9207.52
Drugs, Treatments, Trials
-
266201.78
-
51972.47
-
11356.87
-
10099.14
-
5849.53
-
5464.22
-
4434.67
-
4259.74
-
1818.06
-
1805.17
Last updated at 13:10 GMT
